Related references
Note: Only part of the references are listed.Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
N. C. Tebbutt et al.
ANNALS OF ONCOLOGY (2011)
Treatment of Pituitary Neoplasms With Temozolomide A Review
Luis V. Syro et al.
CANCER (2011)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Ann I. McCormack et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
Olga Moshkin et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Mechanisms of resistance to antiangiogenesis therapy
Faisal Azam et al.
EUROPEAN JOURNAL OF CANCER (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
Iris Helfrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
Andrew D. Norden et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis
Roy Torcuator et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Colon perforation during antiangiogenic therapy for malignant glioma
Andrew D. Norden et al.
NEURO-ONCOLOGY (2009)
A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
Samuel H. Cheshier et al.
NEUROSURGERY (2009)
Antiangiogenic therapy in malignant gliomas
Andrew D. Norden et al.
CURRENT OPINION IN ONCOLOGY (2008)
Angiogenesis and gliomas: Current issues and development of surrogate markers
Emmanuel Jouanneau
NEUROSURGERY (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion
David Zagzag et al.
LABORATORY INVESTIGATION (2006)
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
N Ferrara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Tyrosine kinases as targets for cancer therapy
DS Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
